PT3166604T - Agentes para o tratamento de doenças infeciosas retrovirais - Google Patents

Agentes para o tratamento de doenças infeciosas retrovirais

Info

Publication number
PT3166604T
PT3166604T PT157568296T PT15756829T PT3166604T PT 3166604 T PT3166604 T PT 3166604T PT 157568296 T PT157568296 T PT 157568296T PT 15756829 T PT15756829 T PT 15756829T PT 3166604 T PT3166604 T PT 3166604T
Authority
PT
Portugal
Prior art keywords
substances
treatment
infectious diseases
retroviral infectious
retroviral
Prior art date
Application number
PT157568296T
Other languages
English (en)
Original Assignee
Immunologik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunologik Gmbh filed Critical Immunologik Gmbh
Publication of PT3166604T publication Critical patent/PT3166604T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT157568296T 2014-07-10 2015-07-10 Agentes para o tratamento de doenças infeciosas retrovirais PT3166604T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102014010220.3A DE102014010220A1 (de) 2014-07-10 2014-07-10 Mittel zur Behandlung retroviraler Infektionen

Publications (1)

Publication Number Publication Date
PT3166604T true PT3166604T (pt) 2021-02-09

Family

ID=54866663

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157568296T PT3166604T (pt) 2014-07-10 2015-07-10 Agentes para o tratamento de doenças infeciosas retrovirais

Country Status (9)

Country Link
US (1) US10588896B2 (pt)
EP (1) EP3166604B1 (pt)
AU (1) AU2015285992A1 (pt)
BR (1) BR112017000543A2 (pt)
CA (1) CA2990298C (pt)
DE (2) DE102014010220A1 (pt)
ES (1) ES2846806T3 (pt)
PT (1) PT3166604T (pt)
WO (1) WO2016004917A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021170290A1 (en) 2020-02-28 2021-09-02 Immunologik Gmbh Inhibitors of human deubiquitinases for the treatment of coronaviral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1930900A (en) 1998-12-04 2000-06-26 University Of Maryland Biotechnology Institute Use of protease inhibitors to modulate cellular pathways, immunity and therapiesassociated therewith
CA2435146C (en) 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
NZ597545A (en) 2006-06-19 2013-07-26 Proteolix Inc Peptide epoxyketones for proteasome inhibition
US8524444B2 (en) * 2007-06-15 2013-09-03 President And Fellows Of Harvard College Methods and compositions for detections and modulating O-glycosylation
CA2735278A1 (en) * 2008-08-28 2010-03-04 Aarhus Universitet Hiv-1 envelope polypeptides for hiv vaccine
US9914717B2 (en) * 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors

Also Published As

Publication number Publication date
DE112015003204A5 (de) 2017-04-06
CA2990298A1 (en) 2016-01-14
BR112017000543A2 (pt) 2018-06-26
EP3166604B1 (de) 2020-11-18
WO2016004917A1 (de) 2016-01-14
CA2990298C (en) 2022-11-08
EP3166604A1 (de) 2017-05-17
AU2015285992A1 (en) 2017-02-23
DE102014010220A1 (de) 2016-01-14
US10588896B2 (en) 2020-03-17
ES2846806T3 (es) 2021-07-29
US20170202814A1 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
IL253062B (en) Pyrazine compounds for the treatment of infectious diseases
IL253052A0 (en) Isoquinoline compounds for the treatment of hiv
IL247515A0 (en) Snekribirock for the treatment of leprosy
SG11201700962SA (en) Disposable diaper
SI3122358T1 (sl) Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka
EP3227276A4 (en) Combinations for the treatment of neuroblastoma
IL247443B (en) Process for the preparation of 5-fluorotryptophol
IL258137B1 (en) HIV treatment measures
SG11201702700UA (en) Methods for the treatment of peri-implantitis
SG11201505434WA (en) Disposable diaper
HUE070257T2 (hu) Vegyületek a lipofuscinhoz kapcsolódó betegségek kezelésére
IL277377B (en) Prohemostatic proteins for the treatment of bleeding
EP3096775A4 (en) Socs mimetics for the treatment of diseases
SG11201408640RA (en) Disposable diaper
PL3373881T3 (pl) Jednorazowy łóżkowy basen sanitarny
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
SG11201408634UA (en) Disposable diaper
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases
GB201412010D0 (en) Treatment of hypertransaminasemia
PL2937084T3 (pl) Sposób leczenia hipercholesterolemii
ZA201704589B (en) Compounds for the treatment of cancer
HK1238246A (en) Iminosugars useful for the treatment of viral diseases
HK1238246A1 (en) Iminosugars useful for the treatment of viral diseases
GB201409434D0 (en) Combinations useful for the treatment of bacterial infectious diseases
AU360378S (en) Disposable diaper